NO152171C - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater

Info

Publication number
NO152171C
NO152171C NO794047A NO794047A NO152171C NO 152171 C NO152171 C NO 152171C NO 794047 A NO794047 A NO 794047A NO 794047 A NO794047 A NO 794047A NO 152171 C NO152171 C NO 152171C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
imidazoline derivatives
analogy procedure
analogy
Prior art date
Application number
NO794047A
Other languages
English (en)
Norwegian (no)
Other versions
NO794047L (no
NO152171B (no
Inventor
Elso Manghisi
Giuseppe Cascio
Giancarlo B Fregnan
Giovanni Ferni
Original Assignee
Inst Lusofarmaco D Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT30738/78A external-priority patent/IT1101727B/it
Priority claimed from IT27202/79A external-priority patent/IT1127215B/it
Application filed by Inst Lusofarmaco D Italia Spa filed Critical Inst Lusofarmaco D Italia Spa
Publication of NO794047L publication Critical patent/NO794047L/no
Publication of NO152171B publication Critical patent/NO152171B/no
Publication of NO152171C publication Critical patent/NO152171C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO794047A 1978-12-12 1979-12-11 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater NO152171C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT30738/78A IT1101727B (it) 1978-12-12 1978-12-12 Nuove 2-fenilammino-imidazoline-(2) sostituite, dotate di particolari proprieta' terapeutiche, loro processo di sintesi e composizioni farmaceutiche
IT27202/79A IT1127215B (it) 1979-11-12 1979-11-12 Nuove 2-fenilammino-imidazoline-(2)sostitutite,dotate di particolari proprieta' terapeutiche,loro processo di sintesi e composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
NO794047L NO794047L (no) 1980-06-13
NO152171B NO152171B (no) 1985-05-06
NO152171C true NO152171C (no) 1985-08-14

Family

ID=26328719

Family Applications (1)

Application Number Title Priority Date Filing Date
NO794047A NO152171C (no) 1978-12-12 1979-12-11 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater

Country Status (13)

Country Link
US (1) US4262006A (de)
CA (1) CA1137090A (de)
CH (1) CH645358A5 (de)
DE (1) DE2949971C2 (de)
DK (1) DK159317C (de)
ES (1) ES8102565A1 (de)
FI (1) FI65428C (de)
FR (1) FR2444036A1 (de)
GB (1) GB2041355B (de)
NL (1) NL183139C (de)
NO (1) NO152171C (de)
PT (1) PT70584A (de)
SE (1) SE430503B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
KR101881115B1 (ko) * 2015-06-25 2018-08-20 가천대학교 산학협력단 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD95843A5 (de) * 1971-01-21 1973-02-20
US3850926A (en) * 1971-01-21 1974-11-26 Boehringer Sohn Ingelheim 2-(n-substituted-phenylamino)-imidazolines-(2)

Also Published As

Publication number Publication date
ES487167A0 (es) 1980-12-16
FI65428C (fi) 1984-05-10
NO794047L (no) 1980-06-13
GB2041355B (en) 1983-02-16
DE2949971A1 (de) 1980-07-03
DK159317B (da) 1990-10-01
SE430503B (sv) 1983-11-21
CH645358A5 (it) 1984-09-28
DE2949971C2 (de) 1983-11-24
FI793727A (fi) 1980-06-13
NL183139B (nl) 1988-03-01
FR2444036B1 (de) 1985-03-15
NL183139C (nl) 1988-08-01
CA1137090A (en) 1982-12-07
NL7908853A (nl) 1980-06-16
DK512479A (da) 1980-06-13
US4262006A (en) 1981-04-14
ES8102565A1 (es) 1980-12-16
FR2444036A1 (fr) 1980-07-11
GB2041355A (en) 1980-09-10
NO152171B (no) 1985-05-06
FI65428B (fi) 1984-01-31
PT70584A (en) 1980-01-01
DK159317C (da) 1991-02-25
SE7910157L (sv) 1980-06-13

Similar Documents

Publication Publication Date Title
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO151622C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO152046C (no) Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO150966C (no) Fremgangsmaate for fremstilling av kationiske stivelsespastaer
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser